BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30549186)

  • 1. The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms.
    Seegmiller AC; Hsi ED; Craig FE
    Cytometry B Clin Cytom; 2019 Jan; 96(1):20-29. PubMed ID: 30549186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
    Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
    Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow Cytometry of B-Cell Neoplasms.
    Kroft SH; Harrington AM
    Clin Lab Med; 2017 Dec; 37(4):697-723. PubMed ID: 29128065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
    El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
    Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review).
    Weisberger J; Wu CD; Liu Z; Wong JY; Melamed MR; Darzynkiewicz Z; Gorczyca W
    Int J Oncol; 2000 Dec; 17(6):1165-77. PubMed ID: 11078802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.
    Boyd SD; Natkunam Y; Allen JR; Warnke RA
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):116-31. PubMed ID: 22820658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma.
    Gomyo H; Shimoyama M; Minagawa K; Yakushijin K; Urahama N; Okamura A; Yamamoto K; Ito M; Chihara K; Hayashi Y; Matsui T
    Haematologica; 2003 Dec; 88(12):1358-65. PubMed ID: 14687988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma.
    Comazzi S; Gelain ME
    Vet J; 2011 May; 188(2):149-55. PubMed ID: 20413335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathological analysis of B-cell non-Hodgkin lymphomas without light chain restriction by using flow cytometry.
    Ohmoto A; Maeshima AM; Taniguchi H; Tanioka K; Makita S; Kitahara H; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Kobayashi Y; Tobinai K
    Leuk Lymphoma; 2015; 56(12):3301-5. PubMed ID: 25813204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies.
    de Tute RM
    Histopathology; 2011 Jan; 58(1):90-105. PubMed ID: 21261686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry.
    Auat M; Cardoso CC; Santos-Pirath IM; Rudolf-Oliveira RCM; Matiollo C; Lange BG; da Silva JP; Dametto GC; Pirolli MM; Colombo MDHP; Santos-Silva MC
    Cytometry B Clin Cytom; 2018 Jul; 94(4):588-595. PubMed ID: 29476700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 expression in mature B-cell neoplasms: a flow cytometry study.
    Marcondes N; Fernandes F; Faulhaber G
    Rev Assoc Med Bras (1992); 2018 Jun; 64(6):525-529. PubMed ID: 30304310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J; Fan G; Zhong Y; Gatter K; Braziel R; Gross G; Bakke A
    Am J Clin Pathol; 2005 Jun; 123(6):826-32. PubMed ID: 15899772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive data analysis for evaluation of B-cell neoplasia by flow cytometry.
    Duque RE
    Methods Cell Biol; 1994; 42 Pt B():231-42. PubMed ID: 7877503
    [No Abstract]   [Full Text] [Related]  

  • 17. Flow cytometric evaluation of B-cell lymphoid neoplasms.
    Craig FE
    Clin Lab Med; 2007 Sep; 27(3):487-512, vi. PubMed ID: 17658404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
    Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
    Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of intraocular lymphoma by flow cytometry.
    Davis JL; Viciana AL; Ruiz P
    Am J Ophthalmol; 1997 Sep; 124(3):362-72. PubMed ID: 9439362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas.
    Wu JM; Vonderheid E; Gocke CD; Moresi JM; Liegeois N; Borowitz MJ
    J Cutan Pathol; 2012 Oct; 39(10):918-28. PubMed ID: 22845743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.